3BSA | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
3BSC | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
3CO9 | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
3CVK | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
3D28 | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL BENZISOTHIAZOLE INHIBITOR |
3D5M | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
3E51 | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL PYRIDAZINONE INHIBITOR |
3GYN | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL MONOCYCLIC DIHYDROPYRIDINONE INHIBITOR |
3H2L | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH A NOVEL BICYCLIC DIHYDRO-PYRIDINONE INHIBITOR |
3H98 | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B 1B WITH (1,1-DIOXO-2H-[1,2, 4]BENZOTHIADIAZIN-3-YL) AZOLO[1,5-A]PYRIMIDINE DERIVATIVE |
3IGV | A:; B: | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH A NOVEL MONOCYCLIC DIHYDRO-PYRIDINONE INHIBITOR |